Revelation Biosciences Executes 1-for-7 Reverse Stock Split and Faces Going Concern Doubt

Filing content

The company executed a 1-for-7 reverse stock split on October 20, 2026, and faces substantial doubt regarding its ability to continue as a going concern due to recurring losses.